Search results
Results from the WOW.Com Content Network
CBT is used to treat both bipolar disorder and schizophrenia. [5] Families of the affected also benefit from this treatment, as they can sit on sessions and talk to the therapist as well. [15] [16] Other type of therapy that can be helpful for people with bipolar disorder and schizophrenia include family therapy, psycho-education, and support ...
Simplified graphical comparison of bipolar I, bipolar II and cyclothymia [111] [112]: 267 More detailed graphical comparison of bipolar I, bipolar II, unipolar depression and cyclothymia. The DSM and the ICD characterize bipolar disorder as a spectrum of disorders occurring on a continuum. The DSM-5 and ICD-11 lists three specific subtypes: [5 ...
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.
The conversion rate for a first episode of drug induced psychosis to bipolar disorder or schizophrenia is lower, with 30% of people converting to either bipolar disorder or schizophrenia. [34] NICE makes no distinction between substance-induced psychosis and any other form of psychosis. The rate of conversion differs for different classes of ...
Emil Kraepelin (1856–1926). The Kraepelinian dichotomy is the division of the major endogenous psychoses into the disease concepts of dementia praecox, which was reformulated as schizophrenia by Eugen Bleuler by 1908, [1] [2] and manic-depressive psychosis, which has now been reconceived as bipolar disorder. [3]
By comparison, diagnostic stability was 92% for schizophrenia, 83% for bipolar disorder and 74% for major depression. [5] Most patients diagnosed with DSM-IV schizoaffective disorder are later diagnosed with a different disorder, and that disorder is more stable over time than the DSM-IV schizoaffective disorder diagnosis. [5]
MEDRS articles about schizophrenia cited by primary sources Adriano, F; Caltagirone, C; Spalletta, G (2011). "Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis".
The average lifetime prevalence found was 6.7% for MDD (with a relatively low lifetime prevalence rate in higher-quality studies, compared to the rates typically highlighted of 5–12% for men and 10–25% for women), and rates of 3.6% for dysthymia and 0.8% for Bipolar 1. [18]